JPMORGAN CHASE & CO - CARDLYTICS INC ownership

CARDLYTICS INC's ticker is and the CUSIP is 14161WAB1. A total of 13 filers reported holding CARDLYTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of CARDLYTICS INC
ValueSharesWeighting
Q3 2022$517,000
-18.7%
800,0000.0%0.00%
Q2 2022$636,000
+15.8%
800,000
+60.0%
0.00%
Q4 2021$549,000
-87.6%
500,000
-85.7%
0.00%
-100.0%
Q3 2021$4,436,0003,500,0000.00%
Other shareholders
CARDLYTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
GUARDIAN POINT CAPITAL, LP 5,000,000$3,783,0002.08%
LINDEN ADVISORS LP 65,612,000$49,513,0000.46%
WOLVERINE ASSET MANAGEMENT LLC 35,978,000$27,036,0000.27%
Teton Advisors, Inc. 1,030,000$779,0000.16%
683 Capital Management, LLC 2,000,000$1,500,0000.11%
CAPSTONE INVESTMENT ADVISORS, LLC 15,000,000$11,316,0000.06%
GABELLI FUNDS LLC 6,920,000$5,234,0000.04%
Citadel Advisors 93,500,000$70,038,0000.02%
GAMCO INVESTORS, INC. ET AL 300,000$227,0000.00%
BARCLAYS PLC 3,141,000$2,344,0000.00%
View complete list of CARDLYTICS INC shareholders